PHILADELPHIA, Oct. 14, 2025 /PRNewswire/ -- Integral Molecular, a leader in developing innovative tools for antiviral research, announces the launch of its Ready Reporter Virus™ (RRV) neutralization ...

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused the emergence of the coronavirus pandemic (COVID-19) that has caused over five million deaths and caused hundreds of millions of ...

In a recent study posted to the bioRxiv* preprint server, researchers used a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike (S) protein-pseudotyped viral model to characterize SARS ...

The MarketWatch News Department was not involved in the creation of this content. Automation-compatible, safe assay delivers same-day results to accelerate vaccine and therapeutic antibody development ...

Only one currently authorized antibody treatment retains its activity against all Omicron subvariants, according to new research by scientists at Columbia University and the University of Hong Kong.

AllAfrica publishes around 600 reports a day from more than 110 news organizations and over 500 other institutions and individuals, representing a diversity of positions on every topic. We publish ...

A new study finds that COVID vaccines and monoclonal antibody treatments offer less protection against new Omicron subvariants. Only one currently authorized antibody treatment retains its activity ...